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Abstract A prior linkage scan in Pima Indians identified a
putative locus for type two diabetes (T2D) and body mass
index (BMI) on chromosome 11q23-25. Association map-
ping across this region identified single nucleotide poly-
morphisms (SNPs) in the trehalase gene (TREH) that were
associated with T2D. To assess the putative connection
between trehalase activity and T2D, we performed a linkage
study for trehalase activity in 570 Pima Indians who had
measures of trehalase activity. Strong evidence of linkage of
plasma trehalase activity (LOD = 7.0) was observed in the
TREH locus. Four tag SNPs in TREH were genotyped in
these subjects and plasma trehalase activity was highly
associated with three SNPs: rs2276064, rs117619140 and
rs558907 (p = 2.2 9 10-11–1.4 9 10-23), and the fourth
SNP, rs10790256, was associated conditionally on these
three (p = 2.9 9 10-7). Together, the four tag SNPs
explained 51 % of the variance in plasma trehalase activity
and 79 % of the variance attributed to the linked locus.
These four tag SNPs were further genotyped in 828 subjects
used for association mapping of T2D, and rs558907 was
associated with T2D (odds ratio (OR) 1.94, p = 0.002).
To assess replication of the T2D association, all four tag
SNPs were additionally genotyped in two non-overlapping
samples of Native Americans. Rs558907 was reproducibly
associated with T2D in 2,942 full-heritage Pima Indians (OR
1.27 p = 0.03) and 3,897 ‘‘mixed’’ heritage Native Ameri-
cans (OR 1.21, p = 0.03), and the strongest evidence for
association came from combining all samples (OR 1.27
p = 1.6 9 10-4, n = 7,667). However, among 320 longi-
tudinally studied subjects, measures of trehalase activity
from a non-diabetic exam did not predict those who would
eventually develop diabetes versus those who would remain
non-diabetic (hazard ratio 0.94 per SD of trehalase activity,
p = 0.29). We conclude that variants in TREH control tre-
halase activity, and although one of these variants is also
reproducibly associated with T2D, it is likely that the effect
of the SNP on risk of T2D occurs by a mechanism different
than affecting trehalase activity. Alternatively, TREH vari-
ants may be tagging a nearby T2D locus.
Introduction
A prior genomic linkage scan in Pima Indians identified an
obesity susceptibility locus on chromosome 11q23-25
(LOD = 3.6). There was also suggestive evidence that the
same genomic region contains a susceptibility locus for
type two diabetes (T2D, LOD = 1.7) (Hanson et al. 1998).
This region of linkage to obesity and/or T2D was replicated
in several other studies including Caucasians who are part
of the Framingham study (Atwood et al. 2002), part of the
Breda Study Cohort (van Tilburg et al. 2003), Utah Cau-
casians (Elbein et al. 1999) and Mexican-Americans who
are part of the GENNID study (Duggirala et al. 2003).
However, no variant in this region on chromosome 11 was
reported to be among the top associations in large-scale
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meta-analyses of genome-wide association data for T2D or
obesity in Caucasians (Zeggini et al. 2008; Morris et al.
2012; Willer et al. 2009).
The region of linkage in Pima Indians spans approxi-
mately 23 Mb, from approximately 112–134 Mb and
contains *345 genes. This segment of chromosome 11
contains the dopamine receptor D2 gene, which is a good
physiologic candidate gene for obesity; however, variations
in this gene do not account for the linkage signal for BMI
in Pima Indians (Jenkinson et al. 2000). In subsequent
association mapping studies, several SNPs with nominally
significant associations with T2D are mapped to or near
TREH, UBASH3B, KIRREL3 and SNX19. Some of the most
strongly associated variants are in or near the potential
candidate gene TREH (Hanson et al. 2006), which codes
for trehalase. In British and Nigerian studies, plasma tre-
halase activity was higher in diabetic subjects than non-
diabetic subjects (Eze 1989). Higher serum trehalase
activity has also been observed in diabetic subjects with
glycosuria compared to diabetic subjects without glycos-
uria (Isichei and Gorecki 1993). In mice, trehalase activity
is also elevated in both alloxan-induced and genetic
(Ob/Ob, Db/Db) diabetic mice (Baumann et al. 1981;
Ramaswamy and Flint 1980). However, the causal direc-
tion underlying this association is not known.
Our association mapping for the T2D locus on chro-
mosome 11q23-25 led us to perform detailed analysis of
the TREH gene structure and its enzymatic activity,
reported herein. Trehalase splits the disaccharide a, a-tre-
halose into two molecules of glucose. This enzyme is found
in bacteria, insects and mammals. In mammals, it is
restricted to the small intestine, kidney, liver and bile (Kalf
and Reider 1958; Kenny and Maroux 1982). In humans, the
physiological function of trehalase is to digest dietary tre-
halose in the small intestine, but its exact role in carbo-
hydrate metabolism is not clear.
One of the notable properties of substrate trehalose is its
ability to protect cellular integrity during desiccation.
Desert plants, bacteria, yeast, mushrooms and insects all
manufacture trehalose as a defense mechanism against
dehydration (Wingler 2002; Elbein et al. 2003). Trehalose
can also protect against oxidative stress (Echigo et al.
2012). In humans, the main dietary sources of naturally
occurring trehalose are mushrooms, baker and brewer’s
yeast and certain kinds of shrimp. However, trehalose’s
unique properties of protecting the integrity of a cell during
desiccation have made it an important additive in the food
and drug industries. It is also commonly used as a sweet-
ener in bakery goods, beverages, confectionery, fruit jam,
breakfast cereals, rice, and noodles (Richards et al. 2002).
Some individuals are unable to absorb trehalose, and the
hereditary trehalose malabsorption is correlated with tre-
halase deficiency. In Greenland, the prevalence of trehalase
deficiency has been reported to be 8 %, which is consid-
erably higher than that seen elsewhere (Gudmand-Høyer
et al. 1988). Recently, this sugar has been widely touted as
an alternative to sucrose in diets proposed to prevent dia-
betes, due to reduced glycaemic and insulinaemic respon-
ses following trehalose ingestion (van Can et al. 2009). On
account of this, and on account of the linkage studies
described above, we sought to explore the relationship
between trehalase activity and T2D and also determine the
genetic basis for trehalase activity.
Methods
Subjects
All subjects in this study are participants of a longitudinal
study of the etiology of T2D among the Gila River Indian
Community in Arizona, where most of the residents are Pima
Indians or Tohono O’odham (a closely related tribe, Knowler
et al. 1978). Diabetic status was determined by an oral glucose
tolerance test according to the criteria of the American Dia-
betes Association (The Expert Committee on the Diagnosis
and Classification of Diabetes Mellitus 1997). The original
observation of genetic linkage on chromosome 11q23-25 was
determined in 966 individuals from 264 nuclear families who
were selected for having family members with T2D (Hanson
et al. 1998). Among these 966 individuals, 828 had complete
data on covariates for association analysis with T2D, and,
thus, were used for association mapping of the suggestive
T2D linkage signal. Characteristics of these 828 individuals
were: 648 (78 %) had T2D; 320 (39 %) were men; mean
(±SD) BMI = 38.4 ± 8.5 kg/m2; and mean age at last exam
=48.3 ± 13.0 years. Replication of SNP associations with
T2D was assessed in two additional, non-overlapping sam-
ples from our longitudinal study on the Gila River Indian
Community. The first replication sample included all addi-
tional individuals who were full-heritage Pima Indian
(n = 2,942): 1,149 (39 %) had T2D; 1,294 (44 %) were men;
mean BMI = 37.1 ± 8.6 kg/m2; and mean age = 37.1 ±
16.6 years. The second replication sample included all
additional individuals who were not full-heritage Pima Indian
(n = 3,897). Heritage in this ‘‘mixed heritage’’ group was, on
average, Pima andAmerican Indian, which may include
other tribes. Among these individuals, 727 (19 %) had T2D;
1,791 (46 %) were men; mean BMI = 34.6 ± 8.8 kg/m2;
and mean age at the last exam = 27.6 ± 13.7 years.
Sequencing of the trehalase gene and genotyping
of SNPs
Sequencing of the TREH coding regions and putative
promoter region was initially done in 39 Pima subjects
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using Big Dye terminator (Applied Biosystems) on an
automated DNA capillary sequencer (model 3730; Applied
Biosystems). These 39 subjects (68 % had T2D) were
selected to maximize identification of genetic variation.
All 39 subjects were from different nuclear Pima Indian
families, and were selected as having the most diverse
combinations of microsatellite markers near the TREH
locus in our linkage study. More recently, complete exome
sequencing was performed in 177 additional full-heritage
Pima Indians (28 % had T2D), each from a different
nuclear family, using next-generation sequencing technol-
ogy (ShanghaiBio Corp., North Brunswick, NJ). In addi-
tion, whole genome sequence data are currently being
generated (Complete Genomics Inc, Mountain View, CA);
to date, genomic data on 30 Pima Indians (17 % had T2D)
are available for analyses.
SNPs identified by sequencing and tag SNPs (in intron and
flanking regions) selected from databases were genotyped for
association analyses using the TaqMan Allelic Discrimina-
tion (AD) Assay (Applied Biosystems) on an ABI Prism 7700
(Applied Biosystems) or SNPlex genotyping System 48-plex
(Applied Biosystems) on an automated DNA capillary
sequencer (model 3730; Applied BioSystems).
Measurement of plasma trehalase activity
Plasma samples for measurement of trehalase activity
levels were available on 570 subjects who were part of the
original linkage study. These samples were drawn during
an exam where the subject was determined to be non-
diabetic. Among these 570 subjects, 320 had follow-up
information from subsequent exams, and 214 of the 320
subjects subsequently developed diabetes. Plasma trehalase
activity was measured using the method adapted from Eze
(1989). In brief, each plasma sample was incubated with or
without substrate trehalose, and glucose concentration was
measured by a glucose oxidase method (Beckman Instru-
ments). The liberated glucose (i.e., the difference) was
taken as trehalase enzyme activity. Each sample was
measured in duplicate and the mean of the two measure-
ments was used in statistical analyses.
Statistical analysis
Statistical analyses were performed using the software of
the SAS Institute (Cary, NC). Linkage analysis of plasma
trehalase activity, as a quantitative trait, was conducted for
sibships by means of variance-components methods (Amos
et al. 1996). The GENEHUNTER program (Pratt et al.
2000) was used to derive multipoint estimates of the pro-
portion of alleles identical by descent at each chromosomal
location for these analyses. Linkage analysis of diabetes,
accounting for the age-specific occurrence of the disease,
was accomplished with a cumulative incidence ‘‘residual’’
method. It uses age and affection status to produce an
‘‘age-adjusted’’ diabetes score that can be analyzed as a
quantitative trait (Hanson and Knowler 1998). Single trait
analysis suggested that both trehalase activity and diabetes
were linked to the same region; therefore, bivariate linkage
analysis was conducted by covariance-components models
(Lange and Boehnke 1983; Almasy et al. 1997) to assess
the extent to which the presumed gene affects both traits.
Detailed linkage analysis methods have been described
previously (Hanson et al. 1998).
The general association of genotypes with T2D was
assessed with logistic regression analysis and was adjusted
for covariates (age, sex, birth year and heritage). The
model was fit with a generalized estimating equation
(GEE) technique to account for correlation among siblings.
Genotype was analyzed as a numeric variable representing
the number (0, 1, 2) of copies of a given allele (i.e., an
‘‘additive’’ model). Estimates of the proportion of Euro-
pean ancestry were derived by the method of Hanis et al.
(1986) from 45 informative markers with large differences
in allele frequency between populations (Tian et al. 2007)
for use as a covariate in these analyses. The association of
trehalase activity with genotype was assessed by a linear
mixed model that incorporated a random effect to account
for the correlation among siblings in addition to fixed
effects for genotype, age and sex. p values were calculated
by the likelihood ratio test. Linkage disequilibrium (LD),
haplotype blocks and haplotype frequencies were analyzed
by Haploview (version 4.2) (Gabriel et al. 2002).
The extent to which associations could explain the
linkage signal was assessed by a model that tests the
amount by which an associated polymorphism reduces
the variance attributed to the linked locus (Hanson and
Knowler 2008). This method fits a bivariate linkage model
to the original trait and to the residual adjusted for geno-
type. To assess the potential independent contribution of
multiple associated SNPs, conditional analyses were con-
ducted in which a SNP of interest was added to a model
containing one or more additional SNPs. These analyses
were conducted in a ‘‘step-wise’’ fashion to identify a set of
SNPs that were associated with the trait of interest. Hap-
lotypes were analyzed by a modification of the zero
recombinant haplotyping method as previously described
(Vozarova de Courten et al. 2005). Briefly, the MLINK
program is used to calculate the probability that each
individual carries one or two copies of each haplotype,
given their genotypes and the genotypes of their family
members. These probabilities are then used to conduct the
analysis for each haplotype in a fashion analogous to that
for single SNP.
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Results
Association mapping of the region of suggestive
linkage to T2D
To identify the variant(s) that gave rise to the suggestive
linkage signal to T2D on chromosome 11q, 2882 SNPs
were genotyped in 828 subjects and analyzed for associa-
tion with T2D. These markers span 23 Mb of chromosome
11 (position 111 Mb- 134 Mb, NCBI build 36) with an
inter-SNP distance of \10 Kb. Their associations with
T2D (p values \10-3) are mapped to or near TREH,
UBASH3B, KIRREL3 and SNX19. (Fig. 1, p values\10-3,
adjusted for age, sex and birth year). The strongest asso-
ciations with T2D were clustered around 118 Mb which
contains the TREH locus (adjusted p \0.002); therefore,
SNP variation at this locus, and trehalase activity were
further studied in Pima Indians.
Linkage and association mapping of TREH activity
Trehalase activity was measured in plasma samples from
570 Pima Indians who were determined to be non-diabetic
when their blood was drawn. In these 570 subjects, linkage
analysis showed strong linkage (LOD = 7.0) of plasma
trehalase activity to markers on Chromosome 11q23 at
131 cM, near the TREH locus (Fig. 2). The linkage peak
mapped in the vicinity of three microsatellite markers,
D11S1998, D11S4464 and D11S912, which coincided
with the suggestive linkage peak for age-adjusted T2D
(LOD = 1.7) at 137 cM. Since both trehalase activity and
T2D were linked to the same region, a multipoint bivariate
analysis was conducted to assess the extent to which a
single locus may affect both traits. Although bivariate
analysis showed a LOD of 7.0, the estimated genetic cor-
relation between the trehalase and T2D loci (r = -0.47) is
not statistically significantly different from 0 (p = 0.09), as
expected if linkage were coincidental, nor is it significantly
different from -1 (p = 0.23), as expected with high plei-
otropy. Thus, linkage analysis in the present set of families
has limited power to resolve the extent of overlap between
variants affecting trehalase levels and diabetes risk, and
further association studies were conducted.
The 2882 SNPs genotyped for association mapping of
the T2D signal on chromosome 11 were analyzed for
association with TREH activity. Multiple SNPs that map-
ped within the TREH locus had very strong associations
with TREH activity (Fig. 3; p values adjusted for age and
sex).
Sequencing of TREH and selection of tag SNPs
To search for potentially functional variants in the TREH
gene, 16 exons and *2 kb of the upstream region of the
TREH gene were sequenced in 39 Pima Indians. Four
common coding variants (all had a minor allele frequency
C0.28) were identified: rs10790256 (Lys52Lys), rs2276065
(Thr389Ala), rs2276064 (Arg486Trp) and rs7928371
(Gly541Gly). Recently, whole exome sequence data have
been obtained in 177 full-heritage Pima Indians and no
additional coding variants in the TREH gene were identified
in this larger sample. Whole genome sequence data are also
being generated, and among 30 genomes currently avail-
able, two additional rare coding variants were identified:
rs200479357 (Val518Ile) and a novel Leu367Leu (G/T).
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Fig. 1 Association analyses
with T2D for 2882 SNPs which
span 23 Mb of chromosome 11
(position:111 Mb-134 Mb,
NCBI B36) in 828 family-based
full-heritage Pima subjects who
participated in the linkage
study. p values were adjusted
for age and sex. Association
with T2D was analyzed using a
‘‘model-based standard error’’
method. SNPs with a minor
allele frequency \0.05 were
omitted in the plots
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rare SNPs were omitted from further study. Sequencing in
the 39 subjects also identified eight variants that mapped in
the intron/exon junctions or promoter regions: TREH-E2B
(C/T, ?83 bp in intron4, novel), rs673770, rs642497,
rs647878, rs10892251, rs692750, rs117619140 and
rs745663. To provide a denser coverage of information
across this gene, ten additional SNPs (rs607527, rs642530,
rs525485, rs11216943, rs558907, rs561845, rs582630,
rs519982, rs502601, rs644498), positioned in intron 1 and
upstream flanking regions (up to -17 kb) of the TREH
gene, were selected to determine the pattern of linkage
disequilibrium. These SNPs were selected from either our
initial systematic association mapping at an average inter-
SNP distance of \10 kb across this region, or SNPs from
the Affymetrix one million SNP array which had previously
been used for genome-wide association studies in Pima
Indians (Malhotra et al. 2011). The pattern of LD across the
TREH locus was evaluated by genotyping these variants in
828 Pima Indians (Fig. 4a) and 96 healthy Caucasian
samples (commercially available from Sigma-Aldrich)
(Fig. 4b). Among 21 SNPs (the novel intronic variant
TREH-E2B had a minor allele frequency \0.01 and was
therefore omitted), four tag SNPs were selected (using r2
[0.8 to indicate redundancy): rs2276064 (Trp486Arg),
rs117619140 (intron11), rs10790256 (Lys52Lys, captured
rs7928371, rs745663, rs2276065) and rs558907 (a promoter
SNP, captured all intron 1 and promoter SNPs: rs607527,
rs692750, rs10892251, rs647878, rs673770, rs642530,
rs642497, rs525485, rs11216943, rs561845, rs582630,
rs519982 rs502601 and rs644498. Recent whole genome
sequence data of 30 Pima Indians showed that these four tag
SNPs captured all 104 common SNPs (minor allele fre-
quency C0.1) in the TREH gene (r2 [ 0.8, Supplemental
Figure 1A). These four SNPs also served as tags for Cau-
casian samples.
Association of tag SNPs with trehalase activity
The four tag SNPs were genotyped in the 570 Pima Indians
who had measures of plasma trehalase activity. Table 1
shows the mean trehalase activity (enzyme units) by
genotype. Trehalase enzyme activity was highly associated
with three tag SNPs: rs2276064 (Arg486Trp), rs117619140
(intron 11) and rs558907 (promoter) (p \ 1 9 10-10 for
all, adjusted for age and sex). The fourth tag SNP
rs10790256 (Lys52Lys) was not by itself significantly
associated with trehalase activity. When SNPs were tested
as to whether the association resulted in a significant

























Fig. 2 Multipoint results for linkages with plasma trehalase activity
and T2D in/near the TREH locus on chromosome 11q23. Distances
are from the p-terminal end of the chromosome, on the basis of a
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Fig. 3 Association analyses
with trehalase activity for 2882
SNPs which span 23 Mb of
chromosome 11
(position:111 Mb-134 Mb,
NCBI B36) in 570 non-diabetic
Pima subjects who are part of
the linkage study. p values were
adjusted for age and sex. SNPs
with a minor allele frequency
\0.05 were omitted in the plots
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reduction in the linkage signal to trehalase activity on
chromosome 11q23, the amino acid substitution rs2276064
(Arg486Trp) and rs117619140 (intron 11) produced a sta-
tistically significant reduction in the variance attributed to
the linked locus (Table 1).
To determine the extent to which multiple variants might
contribute to association and linkage with plasma trehalase
activity, conditional analyses were conducted in a step-wise
fashion. The variant rs117619140 had the strongest asso-
ciation, and when it was included in the model, the SNP
with the strongest conditional association among the
remaining SNPs was rs558907 (p = 3.3 9 10-8). When
both rs117619140 and rs558907 were included in the
model, rs2276064 had the strongest conditional association
(p = 5.0 9 10-36), and when rs117619140, rs558907 and
rs2276064 were all included, there was an additional con-
tribution of rs10790256 (p = 2.9 9 10-7). Thus, together
all four tag SNPs are associated with plasma trehalase
activity. Likewise, conditional on the effect of rs2276064,
there was a significant reduction in the linkage when
rs558907 was added to the model (p = 0.0035). Condi-
tional on the effects of rs2276064 and rs558907, neither
rs117619140 nor rs10790256 produced a statistically sig-
nificant reduction in the linkage variance (p [ 0.05). When
Fig. 4 Relative positions of 21
SNPs in and near the TREH
locus (chr11:
118034337-118072696, NCBI
B36) and pair-wise linkage
disequilibrium among these
SNPs genotyped in 828 Pima
Indians (a) and 96 Caucasians
(b). Haplotype block was
determined using default
confidence interval algorithm
implemented in Haploview 4.2.
A block was created if 95 % of
informative comparisons were
‘‘strong LD’’, ignoring markers
with minor allele frequency
\0.05. LD (D’) is displayed as
the confidence bounds of color
scheme where dark gray
represents ‘‘strong evidence of
LD’’, light gray represents
‘‘uninformative’’ and white
represents ‘‘strong
recombinant’’. The value in the
box indicates r2. Four tag SNPs
indicated by asterisk were
selected based on r2 C 0.8
rs647878 is monomorphic in
Caucasians
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analyzed together, the four tag SNPs explained a large
portion of the linkage signal (Fig. 5a). Association with the
four tag SNPs together accounted for 51 % of the total
variance in plasma trehalase activity and 79 % of the var-
iance attributed to the linked locus. The two SNPs selected
due to a significant reduction in the linkage signal
(rs2276064 and rs558907) also resulted in a strong reduc-
tion in the linkage signal (Fig. 5b); together these two SNPs
explained 47 % of the total variance and 70 % of the var-
iance attributed to the linked locus.
Association of tag SNPs with T2D
The association with T2D is shown for each of the four tag
SNPs in Table 2. Among the 828 individuals who had been
included in the linkage study for T2D, tag SNPs rs2276064
and rs558907 were associated with T2D (Table 2,
respective odds ratios 1.37 per copy of the T allele,
p = 0.037, and 1.93 per copy of the G allele, p = 0.0024
adjusted for age, sex, birth year and heritage). In geno-
typing of additional individuals from the population who
had not participated in the linkage study, tag SNP rs558907
was associated with T2D in both full-heritage Pima Indians
(Table 2, OR 1.27, p = 0.0291, n = 2,942), and in those




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Fig. 5 Linkage of trehalase activity adjusted for rs2276064,
rs117619140, rs10790256 and rs558907 (a); and adjusted for
rs2276064 and rs558907 (b)
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1.21, p = 0.0321, n = 3,897). The strongest association
with T2D was seen in a combined analysis of all subjects
(Table 2, OR 1.27, p = 1.6 9 10-4, n = 7,667). None of
these SNPs were consistently associated with body mass
index (Supplemental Table 1).
Association of haplotypes with trehalase activity
and T2D
To further explore the genetic associations, haplotype
analyses were conducted. Among the four tag SNPs, there
were four common (frequency [0.05) haplotypes. Analy-
ses of trehalase activity showed that haplotype ‘‘A’’
(CGAA), which contained the C allele at rs2276064, the G
allele at rs117619140, the A allele at rs10790256 and the A
allele at rs558907, tended to have the lowest activity
(Fig. 6). Those with haplotype ‘‘D’’ (CTGG), consisting of
the C allele at rs2276064, the T allele at rs117619140, the
G allele at r10790256, and the G allele at rs558907, tended
to have the highest activity. The other haplotypes were
intermediate between these two, with the ‘‘B’’ haplotype
(TGGG) having lower activity than the ‘‘C’’ haplotype
(CGAG). When diabetes was analyzed according to the
same haplotypes, the A haplotype which was associated
with low trehalase activity, was also associated with a low
prevalence of T2D, particularly when homozygous, and the
combination of C and D had the highest prevalence
with diabetes and the highest trehalase activity. However,
there was otherwise little correspondence between the
effect of a haplotype on trehalase activity and diabetes risk.
When the haplotype combinations were ordered according
to their association with the level of trehalase activity,




































































































































































































































































































































































































































































































































































































































































































































































































Fig. 6 Trehalase activity and diabetes in Pima Indians by haplotypes
in TREH. The haplotypes, A, B, C, and D are defined by the variants
in the following order: rs2276064, rs117619140, rs10790256,
rs558907. Haplotype frequencies for those participants in the linkage
study are indicated in parentheses
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TREH activity and T2D prediction
Although all individuals were nondiabetic at the exami-
nation for which trehalase activity was measured, 320 had
been subsequently examined in the longitudinal study and
214 had developed diabetes. Among these individuals
trehalase activity did not significantly predict development
of diabetes (hazard ratio 0.93 per SD increase in trehalase
activity, 95 % CI 0.81–1.07, p = 0.29). In an additional
small nested case–control study comparing 48 individuals
who initially had normal glucose tolerance, but who sub-
sequently developed diabetes, with matched controls who
remained free of diabetes in follow-up (Lindsay et al. 2002,
Krakoff et al. 2003), baseline trehalase activity also did not
predict diabetes (hazard ratio 1.18, 95 % CI 0.75–1.85,
p = 0.48).
Discussion
Plasma trehalase activity is strongly linked (LOD = 7.0) to
a region near the TREH locus on chromosome 11q23 in
570 non-diabetic Pima Indians. Genetic variants in or near
the TREH locus are strongly associated with trehalase
activity and account for a large portion of the linkage
signal. One of these variants, rs558907 is also reproducibly
associated with T2D in three non-overlapping samples of
Pima Indians.
That genetic polymorphisms influence plasma trehalase
activity has been suggested decades ago in Eze (1989). In
his report, a bimodal distribution of activity was observed
in 30 normal Nigerian subjects, suggesting a potential
underlying genetic influence. We identified four tag SNPs
that are associated with the overall trehalase activity in
plasma of Pima Indians. These associations are strong in
that most achieve the statistical threshold typically required
for genome-wide significance (p \ 7.2 9 10-8) (Dud-
bridge and Gusnanto 2008). Together, these SNPs explain
51 % of the variance in trehalase activity and 79 % of the
variance attributed to the linked locus, thus accounting in
large part for the observed linkage signal. This suggests
that these variants are in linkage disequilibrium with
functional variants that influence trehalase activity. It is
noteworthy that in the initial analyses of the effect of TREH
variants on trehalase activity, some of the SNPs had a
negligible effect on the linkage signal, despite strong evi-
dence for association (e.g., rs558907). However, the asso-
ciation with rs558907 produced a substantial and
significant effect on the linkage signal when adjusted for
the effect of rs2276064. This may occur because none of
the SNPs individually accounts for the entire linkage signal
and, in this situation, adjustment for a variant that partially
accounts for the signal may actually enhance power to
detect residual linkage. More broadly, this suggests that
additional susceptibility variants should be sought in
regions implicated by linkage analysis for complex traits
and in which strong associations have been observed that
do little to explain the linkage signal.
Previous studies have linked plasma/serum trehalase
activity to T2D in humans (Eze 1989; Isichei and Gorecki
1993). At present, the mechanism of the association
between trehalase activity and T2D is unknown. Plasma
trehalase activity was higher in subjects with than without
T2D in both Nigerian and British populations (Eze 1989).
Higher serum trehalase activity was also observed in dia-
betic subjects with glycosuria compared to diabetic sub-
jects without glycosuria (Isichei and Gorecki 1993). In
mice, trehalase activity was elevated in both alloxan-
induced and genetic (Ob/Ob, Db/Db) diabetic mice (Bau-
mann et al. 1981; Ramaswamy and Flint 1980). However,
it is not clear whether elevated trehalase activity observed
in these studies is the effect of T2D, or if people with
higher trehalase activity, perhaps due to linked genes, are
more prone to develop T2D. Moreover, no significant
correlation was observed between plasma/serum trehalase
activity and blood glucose levels in these studies or in the
present study (data not shown). Among 241 non-diabetic,
full-heritage Pima Indians who had undergone detailed
metabolic testing and also had serum collected, trehalase
activity was associated with basal carbohydrate oxidation
(p = 0.03, adjusted for age, sex and percentage body fat)
and carbohydrate oxidation under low- and high-dose
insulin stimulations (adjusted p = 0.007 and 0.009,
respectively). Higher trehalase activity was associated with
lower carbohydrate oxidation. However, it remains to be
determined if trehalase is involved in regulation of blood
glucose level and/or glucose oxidation, if trehalase activity
changes secondary to these processes or if both are influ-
enced by correlated factors. A recent study by Boyd et al.
(2009) has indicated that the TREH gene expression was
directly regulated by the transcriptional factor HNF4a via
binding of the TREH promoter in human intestinal epi-
thelial cells. HNF4a has been extensively studied in
hepatocytes and pancreatic b-cells for its role in develop-
ment of MODY (maturity onset diabetes of the young) and
T2D. However, in the present study we did not find that
plasma trehalase activity measured at a non-diabetic stage
directly predicts the development of T2D in Pima Indians,
although our sample size for this analysis (n = 320) may
have low statistical power to detect a modest predictive
effect of trehalase activity on T2D as indicated by the
confidence interval of the hazard ratio (95 % CI
0.81–1.07).
In the present study, a tag SNP in the TREH gene,
rs558907, was associated with T2D in Pima Indians. The
association with T2D was observed initially in individuals
Hum Genet (2013) 132:697–707 705
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who participated in a linkage study for T2D, and consistent
results were observed in other members of the population,
both those of full Pima heritage and those of mixed heri-
tage. The level of statistical significance (p = 1.6 9 10-4),
however, does not achieve that typically required for
genome-wide significance (Dudbridge and Gusnanto
2008), so it remains possible that the diabetes association is
spurious. However, it should be noted that in all of the
genetic studies that have been conducted in Pima Indians to
date, which include genome-wide association studies using
both the 100 K and one Million Affymetrix SNP chips
(Malhotra et al. 2011; Hanson et al. 2007 and unpublished),
the association in TREH remains among the top 15 stron-
gest associations with T2D for variants genotyped in or
near *1800 genes. It is, however, likely that the functional
variant for the T2D association may not be rs558907 or,
given the extent of linkage disequilibrium in the region, in
TREH itself. The flanking region of the TREH gene is in a
large haplotype block and contains several additional
known and predicted genes including PHLDB1 and DDX6
(Supplemental Figure 1B). Because of the high degree of
LD between variants in the TREH locus and nearby loci,
localization of any diabetes association may be difficult.
Ultimately, replication in other populations with lower
LD across this region may be required to determine whe-
ther the association between TREH variants and T2D is
spurious or real. At present, there are few data, except from
Caucasian populations. From 13 TREH SNPs (rs7928371,
rs745663, rs10790256, rs607527, rs692750, rs673770,
rs642530, rs525485, rs11216943, rs561845, rs582630,
rs519982 and rs644498) directly genotyped or imputed in
the large Caucasian DIAGRAM study, meta-analysis has
shown no association between these SNPs with T2D
(Zeggini et al. 2008). In Caucasians, these 13 SNPs were
captured by two tag SNPs, rs10790256 and rs558907.
Although rs558907 was not genotyped in DIAGRAM
study, a proxy, rs692750 (r2 = 1 with rs558907) was
genotyped in DIAGRAM study, and not associated with
T2D in Caucasians (p = 0.79). Further replication studies
in other, particularly non-Caucasian, populations are
required to determine the relative contribution of this gene
to T2D susceptibility.
Our results indicate that SNPs in TREH strongly influ-
ence trehalase activity. However, the exact functional
variant(s) which contribute to the trehalase activity have
not been identified. The programs ‘‘SIFT’’ and ‘‘Poly-
Phen’’, which bioinformatically predict the effects of
coding variants, both predict a ‘‘tolerated’’ effect of
Arg486Trp (rs2276064) on protein function. This does not
necessarily preclude an important effect of this variant on
plasma trehalase activity, but, alternatively, intronic or
promoter variants could be involved in the regulation of
TREH expression. Variant analysis by Ingenuity Pathway
Analysis predicts the loss of promoter function of
rs642530, rs673770 and rs36077162 which are in complete
LD with rs558907 (r2 = 1). Therefore, future functional
studies are required to further define the causative vari-
ant(s) in this gene. Although our association analyses
showed that SNPs in and/or near the TREH gene were
associated with T2D, it remains unclear whether the dia-
betes causative variant(s) are within the TREH gene or a
nearby gene. Furthermore, since there was little corre-
spondence between the effect of TREH haplotypes on tre-
halase activity and diabetes risk, and little evidence that
trehalase activity itself predicts T2D, it is likely that the
associations between TREH variants and T2D are mediated
by a different mechanism than the effects on trehalase
activity.
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